Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001011712-25-000021
Filing Date
2025-09-17
Accepted
2025-09-17 16:57:47
Documents
3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 16120
2 LIMITED POWER OF ATTORNEY sc13g_ex24.htm EX-24 2419
3 JOINT FILING AGREEMENT smlr_sc13g-ex99.htm EX-99 2185
  Complete submission text file 0001011712-25-000021.txt   22604
Mailing Address WINDWARD 1 REGATTA OFFICE PARK, WEST BAY ROAD GRAND CAYMAN E9 KY1-1103
Business Address WINDWARD 1 REGATTA OFFICE PARK, WEST BAY ROAD GRAND CAYMAN E9 KY1-1103 345-949-7576
CAPITAL VENTURES INTERNATIONAL (Filed by) CIK: 0001011712 (see all company filings)

EIN.: 980158206 | Fiscal Year End: 1231
Type: SCHEDULE 13G

Mailing Address 51 E CAMPBELL AVE SUITE 107-D CAMPBELL CA 95008
Business Address 51 E CAMPBELL AVE SUITE 107-D CAMPBELL CA 95008 8777744211
Semler Scientific, Inc. (Subject) CIK: 0001554859 (see all company filings)

EIN.: 261367393 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-88028 | Film No.: 251320773
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)